Truist Financial’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.64M Sell
24,892
-213
-0.8% -$57.7K 0.01% 745
2025
Q4
$6.3M Buy
25,105
+2,706
+12% +$719K 0.01% 760
2025
Q3
$6.43M Sell
22,399
-351
-2% -$94K 0.01% 772
2025
Q2
$5.97M Buy
22,750
+316
+1% +$76.9K 0.01% 769
2025
Q1
$5.22M Sell
22,434
-1,557
-6% -$378K 0.01% 813
2024
Q4
$5.5M Buy
23,991
+84
+0.4% +$19.3K 0.01% 790
2024
Q3
$5.34M Sell
23,907
-1,683
-7% -$370K 0.01% 808
2024
Q2
$5.21M Sell
25,590
-2,671
-9% -$543K 0.01% 842
2024
Q1
$6.17M Sell
28,261
-4,304
-13% -$948K 0.01% 804
2023
Q4
$7.4M Sell
32,565
-94,294
-74% -$19.8M 0.01% 717
2023
Q3
$25.5M Sell
126,859
-20,048
-14% -$4.23M 0.04% 343
2023
Q2
$30.5M Sell
146,907
-5,797
-4% -$1.12M 0.05% 319
2023
Q1
$30.1M Sell
152,704
-8,337
-5% -$1.72M 0.05% 311
2022
Q4
$32.6M Buy
161,041
+37,119
+30% +$7.25M 0.06% 291
2022
Q3
$21.8M Buy
123,922
+207
+0.2% +$42.4K 0.04% 335
2022
Q2
$24.9M Sell
123,715
-26,953
-18% -$5.75M 0.05% 328
2022
Q1
$34.1M Sell
150,668
-9,341
-6% -$2.2M 0.05% 305
2021
Q4
$43.2M Sell
160,009
-993
-0.6% -$246K 0.07% 272
2021
Q3
$38.9M Sell
161,002
-56,301
-26% -$14.2M 0.06% 276
2021
Q2
$51.5M Sell
217,303
-14,405
-6% -$3.28M 0.08% 231
2021
Q1
$50.8M Sell
231,708
-31,726
-12% -$6.37M 0.09% 226
2020
Q4
$46.1M Sell
263,434
-29,833
-10% -$5.15M 0.09% 225
2020
Q3
$47.4M Buy
293,267
+1,229
+0.4% +$195K 0.1% 200
2020
Q2
$41.7M Sell
292,038
-133,336
-31% -$18.4M 0.09% 216
2020
Q1
$46.2M Buy
425,374
+4,053
+1% +$584K 0.12% 182
2019
Q4
$61.2M Buy
421,321
+418,596
+15,361% +$60.4M 0.12% 179
2019
Q3
$393K Sell
2,725
-163
-6% -$23.8K 0.01% 608
2019
Q2
$429K Sell
2,888
-475
-14% -$66.3K 0.01% 607
2019
Q1
$442K Sell
3,363
-1,624
-33% -$200K 0.01% 594
2018
Q4
$542K Sell
4,987
-502
-9% -$67.2K 0.01% 541
2018
Q3
$819K Buy
5,489
+273
+5% +$41.5K 0.01% 501
2018
Q2
$804K Buy
5,216
+747
+17% +$113K 0.02% 511
2018
Q1
$621K Buy
4,469
+1,404
+46% +$206K 0.01% 543
2017
Q4
$420K Buy
3,065
+472
+18% +$62.4K 0.01% 618
2017
Q3
$336K Buy
2,593
+23
+0.9% +$3.07K 0.01% 654
2017
Q2
$341K Sell
2,570
-232
-8% -$28.4K 0.01% 639
2017
Q1
$345K Sell
2,802
-164
-6% -$19.4K 0.01% 640
2016
Q4
$328K Sell
2,966
-489
-14% -$54.3K 0.01% 675
2016
Q3
$408K Sell
3,455
-415
-11% -$48.9K 0.01% 622
2016
Q2
$433K Sell
3,870
-1,210
-24% -$130K 0.01% 615
2016
Q1
$511K Sell
5,080
-950
-16% -$91.1K 0.01% 538
2015
Q4
$641K Sell
6,030
-4,727
-44% -$488K 0.02% 493
2015
Q3
$1M Sell
10,757
-315
-3% -$32.6K 0.03% 408
2015
Q2
$1.15M Sell
11,072
-230
-2% -$23.9K 0.03% 362
2015
Q1
$1.22M Sell
11,302
-939
-8% -$96.6K 0.04% 357
2014
Q4
$1.13M Sell
12,241
-565
-4% -$49.9K 0.03% 360
2014
Q3
$1.12M Sell
12,806
-608
-5% -$54.9K 0.03% 360
2014
Q2
$1.18M Sell
13,414
-916
-6% -$79.3K 0.04% 355
2014
Q1
$1.21M Sell
14,330
-710
-5% -$56.6K 0.04% 342
2013
Q4
$1.18M Sell
15,040
-38
-0.3% -$3.24K 0.04% 341
2013
Q3
$1.28M Buy
15,078
+1,331
+10% +$112K 0.05% 306
2013
Q2
$1.18M Buy
+13,747
New +$1.14M 0.04% 298

Other funds holding LH

Truist Financial's LH Position: Q1 2026 in Review

Truist Financial reduced its Labcorp (LH) stake by 0.85% in Q1 2026, selling an estimated $57.7K and leaving 24,892 shares worth $6.64M. The position accounts for 0.01% of the portfolio, ranked #745.

Truist Financial first reported a position in LH in Q2 2013 and has held it in 52 quarters since. The position peaked at $61.2M in Q4 2019. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Truist Financial held 24,892 shares of Labcorp worth $6.64M as of Q1 2026.
  • Truist Financial sold 213 Labcorp shares in Q1 2026, an estimated $57.7K.
  • Labcorp made up 0.01% of Truist Financial's portfolio in Q1 2026, its #745 holding.
  • Truist Financial first reported a position in Labcorp in Q2 2013 and has held it in 52 quarters since.
  • Truist Financial's Labcorp position peaked at $61.2M in Q4 2019.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Truist Financial's 13F filing for Q1 2026, filed 27 Apr 2026.